Palisade Bio (PALI) Earnings Date, Estimates & Call Transcripts $0.79 +0.01 (+1.51%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$0.78 -0.01 (-1.56%) As of 05/2/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Palisade Bio Earnings Summary Upcoming Q1 Earnings DateMay. 12Before Market OpensEstimatedConsensus EPS (Mar. 24) -$2.39 Actual EPS (Mar. 24) -$0.69 Beat By $1.70 Palisade Bio posted Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.69, which beat the consensus estimate of -$2.39 by $1.70. With a trailing EPS of -$10.92, Palisade Bio's earnings are expected to grow next year, from ($12.43) to ($2.99) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportPALI Upcoming EarningsPalisade Bio's next earnings date is estimated for Monday, May 12, 2025, based on past reporting schedules. Get Palisade Bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Palisade Bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPALI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Palisade Bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.84-$0.84-$0.84Q2 20251-$0.84-$0.84-$0.84Q3 20251-$0.28-$0.28-$0.28Q4 20251-$0.28-$0.28-$0.28 Palisade Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)--------3/24/2025Q4 2024-$2.39-$0.69+$1.70-$0.69--11/12/2024--$3.35-$2.32+$1.03-$2.32--8/12/2024Q2 2024--$3.32 -$3.32-$3.32--5/13/2024Q1 2024--$4.59 -$4.59-$4.59--3/26/2024Q4 2023--$3.75 -$3.75-$3.75--11/9/2023Q3 2023-$6.00-$7.35 -$1.35-$0.49--8/11/2023Q2 2023--$7.95 -$7.95-$0.53--5/12/2023Q1 2023--$8.10 -$8.10-$0.54-$0.25M Palisade Bio Earnings - Frequently Asked Questions When is Palisade Bio's earnings date? Palisade Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on PALI's earnings history. Did Palisade Bio beat their earnings estimates last quarter? In the previous quarter, Palisade Bio (NASDAQ:PALI) reported ($0.69) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.39) by $1.70. Learn more on analysts' earnings estimate vs. PALI's actual earnings. How much revenue does Palisade Bio generate each year? Palisade Bio (NASDAQ:PALI) has a recorded annual revenue of $250,000.00. How much profit does Palisade Bio generate each year? Palisade Bio (NASDAQ:PALI) has a recorded net income of -$12.30 million. PALI has generated -$10.92 earnings per share over the last four quarters. What is Palisade Bio's EPS forecast for next year? Palisade Bio's earnings are expected to grow from ($12.43) per share to ($2.99) per share in the next year. More Earnings Resources from MarketBeat Related Companies Marker Therapeutics Earnings Date NeuroSense Therapeutics Earnings Date 23andMe Earnings Date MEI Pharma Earnings Date Synlogic Earnings Date NextCure Earnings Date Imunon Earnings Date Minerva Neurosciences Earnings Date Rallybio Earnings Date Relmada Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:PALI) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredAI Boom Takes a Shocking Turn…What 99% of Investors are Missing in AI I believe it could be worth a fortune in the near future, yet hardl...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palisade Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palisade Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.